Rapid Target Identification in Drug Discovery
Mass spectrometry (MS) has the potential to accelerate the delivery of drug development candidates. The ability to acquire relevant data using MS can be limited by the speed of sample analysis.
The latest advances in high-throughput technology overcome time restrictions, providing high-speed sampling and ultrafast automated solid phase extraction. These advances unlock the ability to analyze samples 10 times faster than traditional LC/MS systems.
This case study explores how a high-throughput MS system rapidly generates label-free, biologically relevant data for drug discovery applications.
Download this case study to explore:
- The cost of outsourcing MS analysis
- How to overcome bottlenecks in MS workflows
- Optimized analysis methods for rapidly generating high-quality data